{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:42:00Z","timestamp":1781804520259,"version":"3.54.5"},"reference-count":105,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.path.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T07:00:45Z","timestamp":1728457245000},"page":"157-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Renal Neoplasia"],"prefix":"10.1016","volume":"18","author":[{"given":"Sounak","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Cheville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hoc.2023.04.013","article-title":"Hereditary renal cell carcinoma syndromes","volume":"37","author":"Carlo","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-021-00308-8","article-title":"Wilms tumour","volume":"7","author":"Spreafico","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41581-019-0112-0","article-title":"The genetic changes of Wilms tumour","volume":"15","author":"Treger","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.path.2024.09.001_bib6","doi-asserted-by":"crossref","first-page":"1761030","DOI":"10.1155\/2019\/1761030","article-title":"Clinical features, Treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature","volume":"2019","author":"Torresan","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/clinem\/dgad368","article-title":"Phenotypic profiling and molecular mechanisms in hyperparathyroidism-jaw tumor syndrome","volume":"108","author":"Tora","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2169\/internalmedicine.33.123","article-title":"Familial primary hyperparathyroidism complicated with Wilms' tumor","volume":"33","author":"Kakinuma","year":"1994","journal-title":"Intern Med"},{"key":"10.1016\/j.path.2024.09.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.07.014","article-title":"Secondary renal neoplasia following chemotherapy or radiation in pediatric patients","volume":"103","author":"Gupta","year":"2020","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.05.051","article-title":"BRAF mutations in metanephric adenoma of the kidney","volume":"62","author":"Choueiri","year":"2012","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib11","first-page":"1449","article-title":"A\u00a0genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome","volume":"85","author":"Haven","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib12","first-page":"4204","article-title":"Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas","volume":"81","author":"Teh","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","article-title":"CDC73 germline mutation in a family with mixed epithelial and stromal tumors","volume":"124","author":"Vocke","year":"2019","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.path.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.mayocp.2021.08.011","article-title":"Renal neoplasia in hyperparathyroidism-jaw tumor syndrome","volume":"96","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.path.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ejhg.2008.162","article-title":"PTEN hamartoma tumor syndromes","volume":"16","author":"Blumenthal","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.mayocp.2020.09.016","article-title":"Renal neoplasia in cowden syndrome","volume":"95","author":"Gupta","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.path.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/PAS.0000000000002079","article-title":"Renal neoplasia occurring in patients with PTEN hamartoma tumor syndrome : clinicopathologic study of 12 renal cell carcinomas from 9 patients and association with intrarenal \"lipomas\"","volume":"47","author":"Kozman","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.urology.2011.12.025","article-title":"Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome","volume":"79","author":"Mester","year":"2012","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib19","first-page":"1990","article-title":"Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer","volume":"190","author":"Shuch","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.path.2024.09.001_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41525-020-00148-7","article-title":"Early-onset renal cell carcinoma in PTEN harmatoma tumour syndrome","volume":"5","author":"Kim","year":"2020","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.path.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2020.11.024","article-title":"PTEN hamartoma tumor syndrome: a Case of renal cell Carcinoma in a young female","volume":"148","author":"Ramkumar","year":"2021","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13256-018-1863-0","article-title":"A\u00a0family with PTEN mutations with malignancy and an unusually high number of offspring with autism spectrum disorder: a case report","volume":"12","author":"Gruhl","year":"2018","journal-title":"J\u00a0Med Case Rep"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.semdp.2023.11.003","article-title":"von Hippel-Lindau disease-related neoplasia with an emphasis on renal manifestations","volume":"41","author":"Tekin","year":"2024","journal-title":"Semin Diagn Pathol"},{"issue":"22","key":"10.1016\/j.path.2024.09.001_bib24","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1002\/cncr.30893","article-title":"Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test","volume":"123","author":"Nguyen","year":"2017","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.path.2024.09.001_bib25","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/hmg\/ddac066","article-title":"Elongin C (ELOC\/TCEB1)-associated von Hippel-Lindau disease","volume":"31","author":"Andreou","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","article-title":"A\u00a0germline mutation in PBRM1 predisposes to renal cell carcinoma","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J\u00a0Med Genet"},{"issue":"7375","key":"10.1016\/j.path.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A\u00a0SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/gcc.20718","article-title":"Population-based survey of cancer risks in chromosome 3 translocation carriers","volume":"49","author":"Woodward","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"7456","key":"10.1016\/j.path.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"N., Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.path.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A\u00a0novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Farley","year":"2013","journal-title":"Mol Cancer Res"},{"issue":"11","key":"10.1016\/j.path.2024.09.001_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.32615","article-title":"Assessment of risk of hereditary predisposition in patients with melanoma and\/or mesothelioma and renal neoplasia","volume":"4","author":"Gupta","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.path.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41431-023-01448-z","article-title":"Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome","volume":"31","author":"Lalloo","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"10.1016\/j.path.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ajcp\/aqaa176","article-title":"BAP1-Mutated clear cell renal cell carcinoma","volume":"155","author":"Gallan","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2024.09.001_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2022.10.009","article-title":"Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms","volume":"130","author":"Vormittag-Nocito","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2022.07.022","article-title":"The expanding role of BAP1 in clear cell renal cell carcinoma","volume":"133","author":"Kapur","year":"2023","journal-title":"Hum Pathol"},{"issue":"6733","key":"10.1016\/j.path.2024.09.001_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"issue":"5413","key":"10.1016\/j.path.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","article-title":"Renal cell carcinoma with leiomyomatous stroma\" harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a distinct entity","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215725","article-title":"Exploring the hereditary background of renal cancer in Denmark","volume":"14","author":"Christensen","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000443311","article-title":"The microphthalmia-associated transcription factor p.E318K mutation does not play a major role in sporadic renal cell tumors from caucasian patients","volume":"83","author":"Stoehr","year":"2016","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00428-021-03027-3","article-title":"Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma","volume":"479","author":"de la Fouchardiere","year":"2021","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.path.2024.09.001_bib46","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/PAS.0000000000001630","article-title":"Clear cell tumor with melanocytic differentiation and ACTIN-MITF translocation: report of 7 cases of a novel entity","volume":"45","author":"de la Fouchardiere","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng.3146","article-title":"Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes","volume":"47","author":"Durinck","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib48","first-page":"311","article-title":"A\u00a0review of neoplasms with MITF\/MiT family translocations","volume":"37","author":"Wei","year":"2022","journal-title":"Histol Histopathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/his.13439","article-title":"Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH","volume":"72","author":"Xia","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2024.09.001_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.urology.2020.11.025","article-title":"Clinical and molecular characterization of microphthalmia-associated transcription factor (MITF)-related renal cell carcinoma","volume":"149","author":"Lang","year":"2021","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.path.2024.09.001_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PAS.0000000000000603","article-title":"Frequent BRAF V600E mutations in metanephric stromal tumor","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2024.09.001_bib53","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/PAS.0000000000000501","article-title":"Application of BRAF V600E mutation analysis for the diagnosis of metanephric adenofibroma","volume":"39","author":"Mangray","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/PAS.0000000000000377","article-title":"Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma","volume":"39","author":"Udager","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2024.09.001_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cancergen.2017.03.001","article-title":"A\u00a0novel cytogenetic and molecular characterization of renal metanephric adenoma: identification of partner genes involved in translocation t(9;15)(p24;q24)","author":"Catic","year":"2017","journal-title":"Cancer Genet"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib56","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.path.2024.09.001_bib57","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0000000000001864","article-title":"Adult wilms tumor: genetic evidence of origin of a subset of cases from metanephric adenoma","volume":"46","author":"Argani","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2024.09.001_bib58","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0000000000001240","article-title":"Metanephric adenoma-epithelial wilms tumor overlap lesions: an analysis of BRAF status","volume":"43","author":"Wobker","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/his.12509","article-title":"Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma","volume":"66","author":"Pinto","year":"2015","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.path.2024.09.001_bib60","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.humpath.2015.03.019","article-title":"BRAF mutations in pediatric metanephric tumors","volume":"46","author":"Chami","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2024.09.001_bib61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.humpath.2020.10.013","article-title":"Renal neoplasia with papillary architecture involving the pelvicalyceal system","volume":"107","author":"Gupta","year":"2021","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.path.2024.09.001_bib62","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.humpath.2013.05.007","article-title":"PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis","volume":"44","author":"Zhao","year":"2013","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.path.2024.09.001_bib63","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.prp.2018.05.007","article-title":"Extraneuraxial hemangioblastoma: a clinicopathologic study of 10 cases with molecular analysis of the VHL gene","volume":"214","author":"Muscarella","year":"2018","journal-title":"Pathol Res Pract"},{"issue":"7","key":"10.1016\/j.path.2024.09.001_bib64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0000000000002211","article-title":"Recurrent tuberous sclerosis complex\/mammalian target of rapamycin mutations define primary renal hemangioblastoma as a unique entity distinct from its central nervous system counterpart","volume":"48","author":"Wang","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2024.09.001_bib65","first-page":"2131","article-title":"Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma","volume":"8","author":"Kuroda","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib66","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eururo.2014.04.022","article-title":"Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: a previously unreported pattern of ccRCC\u00a0with possible clinical significance","volume":"66","author":"Montironi","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.path.2024.09.001_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.humpath.2022.07.016","article-title":"Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors","volume":"128","author":"Gupta","year":"2022","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.path.2024.09.001_bib68","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.mayocp.2022.03.034","article-title":"Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors","volume":"97","author":"Gupta","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urolonc.2009.08.003","article-title":"Juxtaglomerular cell tumor of the kidney\u2013a new classification scheme","volume":"28","author":"Dong","year":"2010","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.09.001_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/003655998750015656","article-title":"Juxtaglomerular cell tumor without hypertension","volume":"32","author":"Hayami","year":"1998","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.path.2024.09.001_bib71","first-page":"102176","article-title":"Malignant juxtaglomerular cell tumor","volume":"45","author":"Geisler","year":"2022","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.path.2024.09.001_bib72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.humpath.2023.07.004","article-title":"Comparative gene expression profiling reveals differential expression of GATA3 and Wnt signaling in juxtaglomerular cell tumors compared to renal glomus tumors","volume":"139","author":"Kosari","year":"2023","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2024.09.001_bib73","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/cncr.21205","article-title":"Chromosome abnormalities in juxtaglomerular cell tumors","volume":"104","author":"Brandal","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2024.09.001_bib74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.humpath.2007.08.010","article-title":"Loss of chromosomes 9 and 11 may be recurrent chromosome imbalances in juxtaglomerular cell tumors","volume":"39","author":"Capovilla","year":"2008","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2012.04.006","article-title":"Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases","volume":"44","author":"Kuroda","year":"2013","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib76","doi-asserted-by":"crossref","first-page":"100492","DOI":"10.1016\/j.modpat.2024.100492","article-title":"Molecular characterization of juxtaglomerular cell tumors: evidence of alterations in MAPK-RAS pathway","volume":"37","author":"Lobo","year":"2024","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib77","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1038\/s41467-023-41118-8","article-title":"Targetable NOTCH1 rearrangements in reninoma","volume":"14","author":"Treger","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.path.2024.09.001_bib78","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.pas.0000126722.29212.a7","article-title":"Metastatic juxtaglomerular cell tumor in a 52-year-old man","volume":"28","author":"Duan","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib79","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/PAS.0000000000001038","article-title":"Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features","volume":"42","author":"Ren","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2024.09.001_bib80","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2159-8290.CD-16-0267","article-title":"Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney","volume":"6","author":"Mehra","year":"2016","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib81","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0000000000001150","article-title":"VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney","volume":"42","author":"Wang","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib82","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/his.13298","article-title":"Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney","volume":"71","author":"Sadimin","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2024.09.001_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2024.04.003","article-title":"Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: a validation study","volume":"146","author":"Nielson","year":"2024","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib84","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.mayocp.2022.10.017","article-title":"The cytogenetic profile of spindle cell-predominant mucinous tubular and spindle cell carcinoma","volume":"97","author":"Gupta","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anndiagpath.2015.04.004","article-title":"Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma","volume":"19","author":"Peckova","year":"2015","journal-title":"Ann Diagn Pathol"},{"issue":"12","key":"10.1016\/j.path.2024.09.001_bib86","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.urolonc.2021.04.042","article-title":"A\u00a0contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma","volume":"40","author":"Gupta","year":"2022","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.path.2024.09.001_bib87","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41379-020-00667-9","article-title":"Adverse histology, homozygous loss of CDKN2A\/B, and complex genomic alterations in locally advanced\/metastatic renal mucinous tubular and spindle cell carcinoma","volume":"34","author":"Yang","year":"2021","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib88","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","article-title":"Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals","volume":"3","author":"Forde","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib89","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/PAP.0000000000000321","article-title":"Low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: an update on biologic potential, morphologic spectrum, and differential diagnosis with other low-grade oncocytic tumors","volume":"28","author":"Hamza","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib90","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00428-018-2420-3","article-title":"Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation","volume":"473","author":"da Cunha","year":"2018","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib91","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A\u00a0Clinicopathologic and molecular Analysis of fumarate hydratase-deficient renal cell Carcinoma in 32 patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2024.09.001_bib92","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/10668969211026241","article-title":"Low-grade fumarate hydratase-deficient renal cell carcinoma in a 30-year-old female","volume":"30","author":"Wyvekens","year":"2022","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib93","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.13395","article-title":"Re-evaluation of 33 \u2018unclassified' eosinophilic renal cell carcinomas in young patients","volume":"72","author":"Li","year":"2018","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.path.2024.09.001_bib94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","article-title":"A\u00a0distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma","volume":"71","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2024.09.001_bib95","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2024.09.001_bib96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAP.0000000000000335","article-title":"Do we have sufficient evidence to define prognosis for \"low-grade\" fumarate hydratase-deficient renal cell carcinoma?","volume":"29","author":"Gupta","year":"2022","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.09.001_bib97","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2024.09.001_bib98","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/PAS.0000000000002218","article-title":"TFE3 -rearranged PEComa\/PEComa-like neoplasms : report of 25 new cases expanding the clinicopathologic spectrum and highlighting its association with prior exposure to chemotherapy","volume":"48","author":"Argani","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2024.09.001_bib99","doi-asserted-by":"crossref","first-page":"817","DOI":"10.5858\/arpa.2022-0127-OA","article-title":"Molecular and immunophenotypic correlates of metastatic epithelioid angiomyolipoma include alterations of TP53, RB1, and ATRX","volume":"147","author":"McCarthy","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2024.09.001_bib100","article-title":"Next generation sequencing-based identification of fusion-driven renal neoplasia: a single institution experience","author":"Tekin","year":"2023","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.path.2024.09.001_bib101","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41379-018-0051-5","article-title":"RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations","volume":"31","author":"Wang","year":"2018","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.09.001_bib102","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2024.09.001_bib103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/10668969221143455","article-title":"MED15::TFE3 renal cell carcinomas: report of two new cases and review of the literature confirming nearly universal multilocular cystic morphology","volume":"31","author":"Argani","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.path.2024.09.001_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2023.03.008","article-title":"Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature","volume":"136","author":"Doytcheva","year":"2023","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2024.09.001_bib105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jclinpath-2020-206681","article-title":"Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis","volume":"74","author":"Song","year":"2021","journal-title":"J\u00a0Clin Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812400062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812400062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:30:42Z","timestamp":1760074242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187591812400062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S187591812400062X"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2024.09.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Neoplasia","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}